AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,295 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
¿Cuáles son los estados financieros clave de AddLife AB (publ)?
Según el último estado financiero (Form-10K), Brinker International Inc tiene un total de activos de $0, una ganancia neta 손실 de $0
¿Cuáles son los ratios financieros clave para ADDLF?
El ratio corriente de Brinker International Inc es 0, el margen neto es 0, las ventas por acción son $0.
¿Cómo se desglosan los ingresos de AddLife AB (publ) por segmento o geografía?
Brinker International Inc 주요 수익원은 Chili's이며, 최신 수익 발표에서 수익은 4,882,900,000입니다. 지역별로는 United States이 Brinker International Inc의 주요 시장이며, 수익은 5,384,200,000입니다.
¿Es rentable AddLife AB (publ)?
no, según los últimos estados financieros, Brinker International Inc tiene una ganancia neta 손실 de $0
¿Tiene AddLife AB (publ) alguna deuda?
no, Brinker International Inc tiene una deuda de 0
¿Cuántas acciones en circulación tiene AddLife AB (publ)?
Brinker International Inc tiene un total de acciones en circulación de 0